Objectives: To evaluate the utility of intrapartum amnioinfusion (AI) 
among parturients with MSF may stem from several mechanisms that most likely work simultaneously. Meconium's constitutive elements serve as excellent substrates for bacterial growth, s, 9 It is composed of sugars, water, bile acids, and nitrogen compounds; all are required for bacterial growth.
Meconium has also been shown to interfere with enzyme systems that help to make amniotic fluid bacteriostatic. lO, 11 Recently, it was shown that the administration of ampicillin-sulbactam intravenously "at the time of meconium diagnosis (during the intrapartum period) resulted in a significant reduction in IAI and a trend towards reducing PPE. 14 While this prophylactic protocol effectively reduced infectious complications, repeated or singular doses of broadspectrum antibiotics such as ampicillin-sulbactam are of concern. Foremost, this policy cotld lead to a selection of more virulent organisms. Secondly, an increased cost is incurred with the adoption of this prophylactic practice.
Amnioinfusion (AI) has been used to treat variable decelerations of the fetal heart rate and to improve neonatal outcomes in cases complicated by meconium passage. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] Amnioinfusion has also proven effective for reducing the meconium aspiration syndrome. The success of AI for prevention of meconium aspiration syndrome may be secondary to a dilutional effect. 17 21 We designed this retrospective cohort study to address the utility of AI in cases complicated by MSF and its infectious complications. (Tables 1-3 ). The two groups also had similar rates of PPE and IAI (Table 4 ). The lone ex- 
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